A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Window of Opportunity in Preserving Laryngeal Function Trial
- Status
- RECRUITING
- Phase
- PHASE2
Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
- Status
- RECRUITING
- Phase
- PHASE3
A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
- Status
- RECRUITING
- Phase
- PHASE2
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
- Status
- RECRUITING
- Phase
- PHASE2
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- RECRUITING
- Phase
- PHASE2